- Home
- INAB vs NXPL Comparison
INAB vs NXPL Comparison
Compare INAB & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- NXPL
- Stock Information
- Founded
- INAB 2016
- NXPL 1997
- Country
- INAB United States
- NXPL United States
- Employees
- INAB N/A
- NXPL N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- INAB Health Care
- NXPL Telecommunications
- Exchange
- INAB Nasdaq
- NXPL Nasdaq
- Market Cap
- INAB 23.5M
- NXPL 21.9M
- IPO Year
- INAB 2021
- NXPL N/A
- Fundamental
- Price
- INAB $0.36
- NXPL $0.97
- Analyst Decision
- INAB Strong Buy
- NXPL
- Analyst Count
- INAB 3
- NXPL 0
- Target Price
- INAB $7.75
- NXPL N/A
- AVG Volume (30 Days)
- INAB 2.7M
- NXPL 33.1K
- Earning Date
- INAB 11-12-2024
- NXPL 11-14-2024
- Dividend Yield
- INAB N/A
- NXPL N/A
- EPS Growth
- INAB N/A
- NXPL N/A
- EPS
- INAB N/A
- NXPL N/A
- Revenue
- INAB N/A
- NXPL $66,404,000.00
- Revenue This Year
- INAB N/A
- NXPL N/A
- Revenue Next Year
- INAB N/A
- NXPL N/A
- P/E Ratio
- INAB N/A
- NXPL N/A
- Revenue Growth
- INAB N/A
- NXPL 498.52
- 52 Week Low
- INAB $0.22
- NXPL $0.85
- 52 Week High
- INAB $2.48
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- INAB 50.42
- NXPL 51.01
- Support Level
- INAB $0.31
- NXPL $1.09
- Resistance Level
- INAB $0.37
- NXPL $1.17
- Average True Range (ATR)
- INAB 0.04
- NXPL 0.07
- MACD
- INAB 0.01
- NXPL 0.01
- Stochastic Oscillator
- INAB 38.51
- NXPL 58.76
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.